Analyst picks & changes

Genzyme Corp.


David Molowa of Bear, Stearns downgraded Genzyme Corp. to "hold" from "buy" due to lower earnings expectations in 1994 and beyond. While sales growth of currently marketed products is slowing and new products remain in development, the share

Read the full 414 word article

How to gain access

Continue reading with a
two-week free trial.